Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-27 Purchase |
2021-08-30 09:11 am |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman 10% Owner |
900 | $4.9727 | $4,475 | 97,090 (Indirect Direct) |
View |
2021-08-26 Purchase |
2021-08-27 6:02 pm |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman 10% Owner |
400 | $4.95 | $1,980 | 119,997 (Direct) |
View |
2021-08-23 Purchase |
2021-08-25 08:15 am |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman 10% Owner |
550 | $4.4318 | $2,438 | 82,340 (Direct) |
View |
2021-08-19 Purchase |
2021-08-23 5:55 pm |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
800 | $4.04 | $3,232 | 119,597 (Direct) |
View |
2021-08-19 Purchase |
2021-08-23 08:24 am |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
2,400 | $4.0717 | $9,772 | 95,640 (Indirect Direct) |
View |
2021-08-17 Purchase |
2021-08-19 6:10 pm |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
2,000 | $4.2 | $8,400 | 11,850 (Indirect) |
View |
2021-07-23 Purchase |
2021-07-27 4:59 pm |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
2,700 | $4.7552 | $12,839 | 91,240 (Indirect Direct) |
View |
2021-07-23 Purchase |
2021-07-27 4:59 pm |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
1,500 | $4.71 | $7,065 | 118,797 (Direct) |
View |
2021-02-24 Purchase |
2021-02-26 1:21 pm |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
1,215 | $9.1631 | $11,133 | 88,540 (Indirect Direct) |
View |
2021-02-24 Purchase |
2021-02-26 1:16 pm |
Scopus BioPharma Inc. | SCPS | Gibson Robert J Vice Chairman Director |
300 | $9.375 | $2,813 | 300 (Direct) |
View |
2021-02-23 Purchase |
2021-02-24 07:54 am |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
500 | $9.34 | $4,670 | 117,297 (Direct) |
View |
2021-02-23 Purchase |
2021-02-24 07:46 am |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
1,500 | $9.6493 | $14,474 | 87,325 (Indirect Direct) |
View |
2021-02-22 Purchase |
2021-02-23 08:04 am |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
100 | $9.99 | $999 | 116,797 (Direct) |
View |
2021-02-22 Purchase |
2021-02-23 07:55 am |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
450 | $10.05 | $4,523 | 5,350 (Indirect) |
View |
2021-02-19 Purchase |
2021-02-19 10:12 am |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
500 | $10.93 | $5,465 | 116,697 (Direct) |
View |
2021-02-16 Purchase |
2021-02-18 9:22 pm |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman |
5,375 | $10.07 | $54,153 | 85,375 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-11-23 Other |
2021-11-26 5:01 pm |
2021-10-01 2026-09-30 |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman 10% Owner |
3,000,000 | $0 | 0 (Indirect) |
View |
2021-11-23 Other |
2021-11-26 5:01 pm |
2021-10-01 2026-09-30 |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman 10% Owner |
3,000,000 | $0 | 0 (Indirect) |
View |
2021-06-01 Other |
2021-11-17 09:48 am |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Hopper Paul Director |
706,333 | $0 | 2,118,999 (Indirect) |
View |
Ownership |
2021-11-17 09:46 am |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Hopper Paul Director |
0 | $0 | 1,214,526 (Indirect) |
View |
2021-07-31 Other |
2021-08-03 6:50 pm |
2021-10-01 2026-09-30 |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Executive Committee Chairman 10% Owner |
1,068,016 | $0 | 1,068,016 (Indirect) |
View |
2021-07-31 Other |
2021-08-03 6:49 pm |
2020-04-09 2021-07-31 |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman 10% Owner |
1,085,960 | $0 | 1,107,628 (Direct) |
View |
2021-07-31 Conversion |
2021-08-03 6:49 pm |
2020-04-09 2021-07-31 |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman 10% Owner |
8,481 | $0 | 1,107,628 (Direct) |
View |
Ownership |
2021-07-12 8:58 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Horsager Alan M See Remarks |
0 | $0 | 118,200 (Direct) |
View |
Ownership |
2020-12-28 7:48 pm |
2021-03-31 2025-12-15 |
Scopus BioPharma Inc. | SCPS | Hofstein Raphael Director |
0 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-12-28 7:46 pm |
2021-03-31 2025-12-15 |
Scopus BioPharma Inc. | SCPS | Russell Lesley Director |
0 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-12-28 7:44 pm |
2021-03-31 2025-12-15 |
Scopus BioPharma Inc. | SCPS | Weild IV David Director |
0 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-12-28 7:43 pm |
2021-03-31 2025-12-15 |
Scopus BioPharma Inc. | SCPS | Battleman David S. Director |
0 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-12-28 7:41 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Buckel David A. Director |
0 | $0 | 105,941 (Indirect) |
View |
Ownership |
2020-12-15 7:25 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Gibson Robert J Vice Chairman Director |
0 | $0 | 1,188,220 (Direct) |
View |
Ownership |
2020-12-15 7:24 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Sanghrajka Ashish P President |
0 | $0 | 626,702 (Direct) |
View |
Ownership |
2020-12-15 7:24 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Greenspan Ira Scott Director |
0 | $0 | 4,570,002 (Direct) |
View |
Ownership |
2020-12-15 7:23 pm |
N/A N/A |
Scopus BioPharma Inc. | SCPS | Lamstein Joshua R Chairman |
0 | $0 | 4,495,365 (Direct) |
View |